Accessibility and structure conservation at hepatitis c virus rna target motives to human rnasep

Informations projet

PIRON MARIA

N° de convention de subvention: QLK2-CT-2000-51150

Date de début 1 Decembre 2000

Date de fin 30 Novembre 2002

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 119 408,00

Contribution de l’UE € 119 408,00

Coordonné par

N/A

Objectif

The host laboratory has recently discovered that human RNaseP specifically cleaves the hepatitis C virus RNA in vitro. We will assess whether RNaseP plays any role in the virus life cycle and whether such cleavage may be postulated as a therapeutic target.

Champ scientifique

• natural sciences › biological sciences › microbiology › virology
• medical and health sciences › health sciences › infectious diseases
• natural sciences › biological sciences › genetics › RNA

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

N/A

• Contribution de l’UE: Aucune donnée
• Coût total: Aucune donnée